相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures
Dae Ho Lee
PHARMACOLOGY & THERAPEUTICS (2017)
A novel PTPN1 splice variant upregulates JAK/STAT activity in classical Hodgkin lymphoma cells
Malena Zahn et al.
BLOOD (2017)
JAK-STAT signaling in cancer: From cytokines to non-coding genome
Jan Pencik et al.
CYTOKINE (2016)
Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer
Pooja G. Talati et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenstrom's macroglobulinemia
Lucy S. Hodge et al.
BLOOD (2014)
Clinical Significance of EML4-ALK Fusion Gene and Association with EGFR and KRAS Gene Mutations in 208 Chinese Patients with Non-Small Cell Lung Cancer
Ying Li et al.
PLOS ONE (2013)
Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21Cip1/WAF1 and p27Kip1
Min Wei et al.
CELLULAR ONCOLOGY (2013)
Biology and significance of the JAK/STAT signalling pathways
Hiu Kiu et al.
GROWTH FACTORS (2012)
Combining chemotherapy with epidermal growth factor receptor inhibition in advanced non-small cell lung cancer
Linda Leung et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2012)
Targeted Blockage of Signal Transducer and Activator of Transcription 5 Signaling Pathway with Decoy Oligodeoxynucleotides Suppresses Leukemic K562 Cell Growth
Xiaozhong Wang et al.
DNA AND CELL BIOLOGY (2011)
Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma
Braden C. McFarland et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC models
E. Normant et al.
ONCOGENE (2011)
Inhibition of ALK, PI3K/MEK, and HSP90 in Murine Lung Adenocarcinoma Induced by EML4-ALK Fusion Oncogene
Zhao Chen et al.
CANCER RESEARCH (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma
Olga Ritz et al.
BLOOD (2009)
The EML4-ALK Fusion Gene Is Involved in Various Histologic Types of Lung Cancers From Nonsmokers With Wild-type EGFR and KRAS
Daisy Wing-Sze Wong et al.
CANCER (2009)
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer
Kengo Takeuchi et al.
CLINICAL CANCER RESEARCH (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts
Kengo Takeuchi et al.
CLINICAL CANCER RESEARCH (2008)
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
Jussi P. Koivunen et al.
CLINICAL CANCER RESEARCH (2008)
A mouse model for EML4-ALK-positive lung cancer
Manabu Soda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
Klarisa Rikova et al.
CELL (2007)
Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer
Susobhan Das et al.
PROSTATE (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells
TJ Ahonen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cooperation between STAT3 and c-Jun suppresses Fas transcription
VN Ivanov et al.
MOLECULAR CELL (2001)
分享论文
